LIFEMD INC (LFMD) Stock Overview
NASDAQ:LFMD - US53216B1044 - Common Stock
LFMD Key Statistics, Chart & Performance
The current stock price of LFMD is 6.08 USD. In the past month the price decreased by -9.52%. In the past year, price increased by 15.37%.
LFMD Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 37.94 | 46.19B | ||
| DOCS | DOXIMITY INC-CLASS A | 46.65 | 13.02B | ||
| WAY | WAYSTAR HOLDING CORP | 36.84 | 7.12B | ||
| HTFL | HEARTFLOW INC | N/A | 2.88B | ||
| CERT | CERTARA INC | 22.37 | 1.76B | ||
| PHR | PHREESIA INC | N/A | 1.58B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 11.8 | 1.43B | ||
| SDGR | SCHRODINGER INC | N/A | 1.43B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.38B | ||
| CTEV | CLARITEV CORP | N/A | 1.19B | ||
| EVH | EVOLENT HEALTH INC - A | N/A | 1.17B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.08B |
Related stock screener links
About LFMD
Company Profile
LifeMD, Inc. is a telehealth company, which engages in offering a portfolio of direct-to-patient products and services. The company is headquartered in New York City, New York and currently employs 304 full-time employees. The company went IPO on 2001-07-11. The firm offers telemedicine, access to laboratory and pharmacy services, and specialized treatment across more than 200 conditions, including primary care, men’s and women’s health, weight management, and hormone therapy. The firm operates through two segments: Telehealth and WorkSimpli. Its Telehealth platform is end-to-end virtual healthcare directly to consumers and through select enterprise partnerships. WorkSimpli is a provider of workplace and document services for consumers, gig workers, and small businesses. The company operates brands including: PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild, a provider of digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses.
Company Info
LIFEMD INC
236 Fifth Avenue, Suite 400
New York City NEW YORK 10022 US
CEO: Justin Schreiber
Employees: 306
Phone: 18663515907
LIFEMD INC / LFMD FAQ
What is the stock price of LIFEMD INC today?
The current stock price of LFMD is 6.08 USD. The price decreased by -0.33% in the last trading session.
What is the ticker symbol for LIFEMD INC stock?
The exchange symbol of LIFEMD INC is LFMD and it is listed on the Nasdaq exchange.
On which exchange is LFMD stock listed?
LFMD stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for LIFEMD INC stock?
15 analysts have analysed LFMD and the average price target is 12.82 USD. This implies a price increase of 110.9% is expected in the next year compared to the current price of 6.08. Check the LIFEMD INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is LIFEMD INC worth?
LIFEMD INC (LFMD) has a market capitalization of 273.84M USD. This makes LFMD a Micro Cap stock.
How many employees does LIFEMD INC have?
LIFEMD INC (LFMD) currently has 306 employees.
What are the support and resistance levels for LIFEMD INC (LFMD) stock?
LIFEMD INC (LFMD) has a support level at 6.05 and a resistance level at 6.09. Check the full technical report for a detailed analysis of LFMD support and resistance levels.
Is LIFEMD INC (LFMD) expected to grow?
The Revenue of LIFEMD INC (LFMD) is expected to grow by 23.06% in the next year. Check the estimates tab for more information on the LFMD EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy LIFEMD INC (LFMD) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of LFMD, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of LFMD, evaluating the profitability, health, valuation and growth aspects
- LIFEMD INC (LFMD) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- LIFEMD INC (LFMD) Sales and EPS estimates to see what analysts future expectations are.
- LIFEMD INC (LFMD) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- LIFEMD INC (LFMD) Insider and Institutional Ownership to learn about the owners and their transactions.
- LIFEMD INC (LFMD) Stock Chart to make your own analysis
- LIFEMD INC (LFMD) Latest news and press-releases to stay up to date.
Does LIFEMD INC (LFMD) stock pay dividends?
LFMD does not pay a dividend.
When does LIFEMD INC (LFMD) report earnings?
LIFEMD INC (LFMD) will report earnings on 2025-11-05, after the market close.
What is the Price/Earnings (PE) ratio of LIFEMD INC (LFMD)?
LIFEMD INC (LFMD) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.21).
What is the Short Interest ratio of LIFEMD INC (LFMD) stock?
The outstanding short interest for LIFEMD INC (LFMD) is 17.22% of its float. Check the ownership tab for more information on the LFMD short interest.
LFMD Technical Analysis
LFMD Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to LFMD. LFMD has a bad profitability rating. Also its financial health evaluation is rather negative.
LFMD Financial Highlights
Over the last trailing twelve months LFMD reported a non-GAAP Earnings per Share(EPS) of -0.21. The EPS increased by 70% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -12.28% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
LFMD Forecast & Estimates
15 analysts have analysed LFMD and the average price target is 12.82 USD. This implies a price increase of 110.9% is expected in the next year compared to the current price of 6.08.
For the next year, analysts expect an EPS growth of 86.4% and a revenue growth 23.06% for LFMD